ProfileGDS4132 / AFFX-r2-Bs-phe-5_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 29% 36% 16% 14% 28% 36% 28% 32% 12% 18% 9% 10% 6% 5% 8% 9% 10% 9% 6% 8% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10169.859429
GSM201543Muscle PCOS pioglitazone 12183.723736
GSM201544Muscle PCOS pioglitazone 16134.612816
GSM201545Muscle PCOS pioglitazone 20133.029114
GSM201829Muscle PCOS pioglitazone 23172.978428
GSM201830Muscle PCOS pioglitazon 25193.613536
GSM201831Muscle PCOS pioglitazone 27166.730328
GSM201832Muscle PCOS pioglitazone 3181.396632
GSM201833Muscle PCOS pioglitazone 4121.441912
GSM201834Muscle PCOS pioglitazone 8136.559818
GSM201835Muscle PCOS after pioglitazone 10214.31439
GSM201836Muscle PCOS after pioglitazone 12216.639810
GSM201837Muscle PCOS after pioglitazone 16211.29596
GSM201838Muscle PCOS after pioglitazone 20211.26855
GSM201839Muscle PCOS after pioglitazone 23215.21778
GSM201840Muscle PCOS after pioglitazone 25216.77489
GSM201841Muscle PCOS after pioglitazone 27216.456410
GSM201842Muscle PCOS after pioglitazone 3213.9139
GSM201843Muscle PCOS after pioglitazone 4213.33916
GSM201844Muscle PCOS after pioglitazone 8214.82958